| Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial SR Mehta, S Yusuf, R Díaz, J Zhu, P Pais, D Xavier, E Paolasso, R Ahmed, ... Journal of the American Medical Association 293 (4), 437-446, 2005 | 772 | 2005 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 249 | 2018 |
| Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease G Reis, PA Marcovitz, AB Leichtman, RM Merion, WP Fay, SW Werns, ... The American journal of cardiology 75 (10), 707-710, 1995 | 149 | 1995 |
| Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac … AM Shah, B Claggett, NK Sweitzer, SJ Shah, IS Anand, E O’Meara, ... Circulation: Heart Failure 7 (5), 740-751, 2014 | 132 | 2014 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet, 2019 | 130 | 2019 |
| III Diretriz sobre tratamento do infarto agudo do miocárdio LS Piegas, A Timerman, JC Nicolau, LA Mattos, JM Rossi Neto, ... Arq Bras Cardiol 83 (supl 4), 9-86, 2004 | 130 | 2004 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 116 | 2018 |
| A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia SS Awad, AH Rodriguez, YC Chuang, Z Marjanek, AJ Pareigis, G Reis, ... Clinical Infectious Diseases 59 (1), 51-61, 2014 | 113 | 2014 |
| Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis G Reis, MS Motta, MM Barbosa, WA Esteves, SF Souza, EA Bocchi Journal of the American College of Cardiology 43 (3), 393-401, 2004 | 102 | 2004 |
| Management of acute coronary syndromes in developing countries: acute coronary events—a multinational survey of current management strategies Access Investigators American heart journal 162 (5), 852-859. e22, 2011 | 99 | 2011 |
| Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ... Journal of the American Heart Association 5 (3), e002197, 2016 | 65 | 2016 |
| Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial AP Maggioni, SJ Greene, GC Fonarow, M Böhm, F Zannad, SD Solomon, ... European heart journal 34 (40), 3117-3127, 2013 | 55 | 2013 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet, 2019 | 38 | 2019 |
| III Diretriz sobre tratamento do infarto agudo do miocárdio Á Avezum, ACC Carvalho, AP Mansur, A Timerman, AC Guimarães, ... Arquivos Brasileiros de Cardiologia 83, 1-86, 2004 | 35 | 2004 |
| Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention M Vaduganathan, RA Harrington, GW Stone, EN Deliargyris, PG Steg, ... Journal of the American College of Cardiology 69 (2), 176-185, 2017 | 28 | 2017 |
| Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry FWA Verheugt, H Gao, W Al Mahmeed, G Ambrosio, P Angchaisuksiri, ... European heart journal 39 (6), 464-473, 2017 | 14 | 2017 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The Lancet Diabetes & Endocrinology 7 (8), 618-628, 2019 | 10 | 2019 |
| Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists DA Fitzmaurice, G Accetta, S Haas, G Kayani, H Lucas Luciardi, ... British journal of haematology 174 (4), 610-623, 2016 | 10 | 2016 |
| Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT) CB Overgaard, V Džavík, CE Buller, L Liu, W Banasiak, G Devlin, ... International journal of cardiology 168 (3), 2416-2422, 2013 | 9 | 2013 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 5 | 2019 |
Scott SolomonBrigham and Women's HospitalDirección de correo verificada de rics.bwh.harvard.edu
